Conditions: Coronary Artery Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 19102
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the effect of ivabradine on cardiovascular events in patients with coronary artery disease.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ivabradine intervention 2: Placebo
Intervention descriptions: intervention 1: 5 mg, 7.5 mg or 10 mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 48 months. intervention 2: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 48 months.

Protocol document: